DxUpClose

DxUpClose, Inc., founded in Frisco, Texas, is dedicated to revolutionizing bacterial diagnostics with its rapid point-of-care solutions. The company's core mission is to provide quick and accurate antibiotic sensitivity tests within sixty minutes, addressing the critical need for timely and effective treatment of bacterial infections. DxUpClose offers a diagnostic product that not only screens for specific bacteria but also counts the present bacteria and performs antibiotic sensitivity tests, ensuring comprehensive analysis and aiding in the fight against antibiotic resistance.

Notable figures associated with DxUpClose include its team of experienced microbiologists and healthcare professionals who drive the company's innovative efforts. The startup has garnered attention from investors focused on healthcare technology and rapid diagnostics. Key achievements include the development of their flagship product, which significantly reduces the time required for bacterial testing compared to traditional methods. DxUpClose's impact lies in its potential to improve patient outcomes by enabling faster, more targeted treatments, ultimately contributing to better healthcare practices and combating antibiotic resistance on a broader scale.